Hyaluronan-Induced CD44-iASPP Interaction Affects Fibroblast Migration and Survival

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• The inhibitor of apoptosis-stimulating protein of p53 (iASPP) is a key regulator of cell survival and apoptosis.
• The hyaluronan receptor CD44 is involved in cell adhesion, migration, and cancer progression.
• Interactions between iASPP and CD44 have not been previously elucidated.

Purpose of the Study:

• To investigate the physical interaction between iASPP and CD44 in normal and transformed cells.
• To determine the specific CD44 isoform involved in the interaction.
• To elucidate the functional consequences of the iASPP-CD44 interaction on cell behavior.

Main Methods:

• Co-immunoprecipitation assays to detect protein-protein interactions.
• Analysis of CD44 standard (CD44s) and variant (CD44v) isoforms.
• Hyaluronan stimulation experiments in fibroblasts and epithelial cells.
• Western blotting to assess protein levels and localization.
• Cell migration and adhesion assays.
• Reactive oxygen species (ROS) measurements.
• Gene silencing techniques (knock-down) to study protein function.

Main Results:

• iASPP physically interacts with the CD44 standard isoform (CD44s), but not CD44v.
• The ankyrin-binding domain of CD44s mediates iASPP binding.
• Hyaluronan stimulation promotes iASPP-CD44s complex formation in fibroblasts.
• iASPP is essential for hyaluronan-induced CD44-dependent fibroblast migration and adhesion.
• CD44 influences the sub-cellular localization of the iASPP-p53 complex, affecting p53 activity.
• iASPP overexpression decreases ROS, while CD44 increases ROS levels.
• CD44s knock-down, in the presence of p53, enhances fibroblast proliferation and density.

Conclusions:

• The interaction between iASPP and CD44s is a critical determinant of fibroblast migration, adhesion, and survival.
• Modulation of iASPP-CD44 and iASPP-p53 complex balance impacts cellular fate.
• Targeting the iASPP-CD44 interaction may offer therapeutic strategies for cancer treatment.